| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $15.08 | $0.00 | Buy | 9 | 2026 |
#2 | PARR | United States | $55.66 | $2,443,066,000.00 | Buy | 6 | 2000 |
#3 | AR | United States | $35.56 | $5,275,823,000.00 | Buy | 16 | 2013 |
#4 | CARG | United States | $27.42 | $316,861,000.00 | Buy | 11 | 2017 |
#5 | EQT | United States | $53.75 | $8,644,211,000.00 | Buy | 21 | 1994 |
#6 | NFG | United States | $77.42 | $2,277,541,000.00 | Buy | 4 | 1997 |
#7 | CDE | United States | $16.31 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#8 | SON | United States | $47.49 | $7,518,753,000.00 | Buy | 9 | 2014 |
#9 | FLYW | United States | $14.40 | $623,025,000.00 | Buy | 14 | 2021 |
#10 | CVNA | United States | $66.50 | $20,322,000,000.00 | Buy | 24 | 2017 |
#11 | CSTM | France | $33.89 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#12 | SHAK | United States | $52.34 | $1,445,306,000.00 | Buy | 26 | 2014 |
#13 | DEC | United States | $13.82 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#14 | RELY | United States | $18.77 | $1,635,147,000.00 | Buy | 7 | 2021 |
#15 | VIAV | United States | $47.33 | $1,084,300,000.00 | Strong Buy | 8 | 1996 |
#16 | KNSA | United Kingdom | $48.42 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#17 | ORN | United States | $13.63 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#18 | EYE | United States | $15.44 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#19 | VTR | United States | $82.02 | $5,833,980,000.00 | Buy | 13 | 2005 |
#20 | AORT | United States | $20.12 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#21 | KNTK | United States | $45.19 | $160,617,000.00 | Buy | 12 | 2017 |
#22 | CALX | United States | $37.27 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#23 | DIS | United States | $99.71 | $94,425,000,000.00 | Strong Buy | 16 | 2018 |
#24 | APEI | United States | $52.65 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#25 | SIRI | United States | $27.01 | $5,425,129,000.00 | Buy | 8 | 1996 |
#26 | HNRG | United States | $16.66 | $469,466,000.00 | Strong Buy | 4 | 1995 |
#27 | RUN | United States | $13.36 | $858,578,000.00 | Buy | 20 | 2015 |
#28 | WGO | United States | $27.70 | $1,985,674,000.00 | Buy | 10 | 1994 |
#29 | WBD | United States | $26.25 | $0.00 | Buy | 21 | 2008 |
#30 | NVST | United States | $23.10 | $2,566,500,000.00 | Buy | 13 | 2019 |
#31 | PUMP | United States | $14.74 | $1,269,158,000.00 | Buy | 7 | 2017 |
#32 | ARWR | United States | $73.09 | $16,142,321.00 | Strong Buy | 10 | 2009 |
#33 | CTRE | United States | $37.97 | $476,393,000.00 | Buy | 10 | 2013 |
#34 | VSAT | United States | $67.18 | $0.00 | Strong Buy | 6 | 1996 |
#35 | STOK | United States | $30.01 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#36 | ASMB | United States | $22.90 | $0.00 | Strong Buy | 5 | 2010 |
#37 | ANAB | United States | $50.37 | $234,603,000.00 | Buy | 12 | 2015 |
#38 | ASST | United States | $14.10 | $633,489.00 | Strong Buy | 4 | 2022 |
#39 | KRUS | United States | $45.58 | $282,763,000.00 | Buy | 9 | 2019 |
#40 | CCK | United States | $93.38 | $11,665,000,000.00 | Buy | 16 | 2003 |
#41 | MIRM | United States | $93.48 | $19,138,000.00 | Strong Buy | 13 | 2019 |
#42 | AROC | United States | $34.05 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#43 | AVTX | United States | $13.10 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#44 | AMLX | United States | $13.32 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#45 | LASR | United States | $65.55 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#46 | KGS | United States | $65.11 | $1,308,100,000.00 | Strong Buy | 7 | 2023 |
#47 | BKR | United States | $62.59 | $27,733,000,000.00 | Buy | 17 | 2017 |
#48 | CSV | United States | $37.53 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#49 | SDRL | United States | $44.38 | $1,437,000,000.00 | Buy | 4 | 2018 |
#50 | HCSG | United States | $20.37 | $1,837,173,000.00 | Buy | 6 | 1994 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (June 7, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.